LiverMultiScan

A study has shown that LiverMultiScan-cT1 improved autoimmune hepatitis (AIH) management by identifying patients in biochemical remission as well as patients in deep remission, with undetected, active sub-clinical disease at a high risk of disease relapse. LiverMultiScan-cT1 is an MRI-derived non-invasive tissue biomarker from Perspectum. Patients with AIH often experience recurring periods of subdued disease […]

A study published in PLOS ONE on patients with primary and secondary liver cancer shows how Perspectum’s non-invasive MRI technology Hepatica can help predict those at increased risk of poor surgical outcomes. Hepatica integrates into routine pre-operative MRI assessment and combines pre-surgical measurements of liver health with AI-driven liver volumetry, providing actionable information to inform […]